PURPLE BIOTECH LTD. Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets
PURPLE BIOTECH LTD. (PPBT) reported Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets of $2.08 million for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-09.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets · last filed 2022-03-09
| Period end | Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets 12 month |
|---|---|
| 2021-12-31 | $2.08M 20-F · filed 2022-03-09 |
| 2020-12-31 | $2.65M 20-F · filed 2022-03-09 |
| 2019-12-31 | $2.02M 20-F · filed 2022-03-09 |